Dr. Greg Gordon, MD, Founder/Chief Medical Officer
Originally from Chicago, Dr. Gordon received his undergraduate training at the University of Illinois Champaign-Urbana, with a B.S degree in biochemistry. He performed his medical school training at the University of Illinois Medical School at Chicago. His post doctorate training, including an internship in internal medicine, residency in diagnostic radiology, and fellowship in vascular and interventional radiology, were all completed at Northwestern University. Dr. Gordon has 20 years experience in both private and academic practices, including five years as division head of interventional radiology at Saint Luke’s Hospital/ UMKC medical school Kansas City, Missouri. More recently, Dr. Gordon served as Division Head of Interventional Radiology at the University of Nebraska Medical Center. Soon after starting Radux Devices, Dr. Gordon refocused his attention to the Omaha Veterans Hospital as Director of Interventional Radiology, and in private practice devoted more energy towards his entrepreneurial passions, focusing and promoting standardized occupational and radiation risk management strategies throughout national health care systems.
In addition to his career as a physician, Dr. Gordon has published multiple peer review articles and is a frequent speaker at educational symposiums and continuing medical education venues. His interests in innovation, intellectual property and practice development have provided Dr. Gordon the opportunity to be primary investigator in multiple clinical medical device trials. Through his partnership with UNeMed, Dr. Gordon founded and developed the first two product concepts of Radux Devices, the StandTall and Steradian Shield (Formerly LockBlock).
Kevin Wiersma, Chief Executive Officer
Kevin Wiersma is a proven executive with over 25 years of experience driving strategic, financial, and operating results. Kevin has provided leadership to companies through various phases from turnaround situations to successful sales and exits. Prior to Radux Devices, Kevin held positions as Chief Financial Officer, Chief Operating Officer, and Chief Administrative Officer at MEDTOX Scientific, Inc. and Chief Financial Officer at Therapak Corporation.
Kevin has a B.A. degree from Dordt College.
Richard Braun, MBA, JD
Richard Braun is our Chairman of the Board. Richard (Dick) was formerly CEO and Chairman of the Board of MEDTOX Scientific Inc. (NASDAQ: MTOX) until its sale to LabCorp in July 2012. From 1994 until joining MEDTOX in 1996 Mr. Braun acted as a private investor and provided management consulting services to the health care and technology industries. From 1992 until 1994, he served as Chief Operating Officer and as a director of EBP, Inc., a New York Stock Exchange-listed company engaged in managed care. From 1989 through 1991, Mr. Braun served as Executive Vice President, Chief Operating Officer and as a director of Reich and Tang L.P., a New York Stock Exchange-listed investment advisory and broker dealer firm. Mr. Braun holds a J.D. from the University of Iowa, College of Law, and a Master of Business Administration degree and a Bachelor’s degree from the University of St. Thomas. Mr. Braun has served on a number of public company boards.
Robert Rudell, MBA
Robert Rudell was formerly a director of MEDTOX Scientific, Inc. from April 2002 until the sale of MEDTOX in July 2012(NASDAQ: MTOX). In 1996, Mr. Rudell joined Zurich Scudder Retirement Services as President, and from 1998 to 2002 held the positions of Chief Operating Officer and Chairman of the management committee of Zurich Scudder Investments, a New York City-based asset management firm that is part of Deutsche Asset Management. From 1990 to 1996, he served as President of American Express Institutional Services. Prior to 1990, Mr. Rudell served in a variety of research, marketing and senior management positions with American Express Financial Advisors. Mr. Rudell received his Master of Business Administration degree from the University of Minnesota. Mr. Rudell serves on the boards of the Optimum Mutual Funds, Chairman, The Heartland Group Inc. and American Investors Bank Mortgage.
Andrew Ubel, JD
Andrew Ubel was formerly Deputy General Counsel, Chief Intellectual Property Counsel for Valspar Corporation from January 2000 until the sale of Valspar to Sherwin William in 2018. His responsibilities include managing Valspar’s worldwide patent, trademark, copyright and trade secret legal matters. Prior to joining Valspar, Andy worked for 3M Company, initially as a product development research scientist (where he was named as an inventor on over 25 U.S. patents) and later as a patent attorney. Andy received a B.S. Chem Eng. from MIT; a M.S. Material Science from the University of Minnesota; and a Juris Doc. from William Mitchell College of Law.